Pfizer Wins Dismissal Of Securities Suit Over Drug
In a boost to Pfizer Inc., a federal judge has granted the drug giant's bid to toss the amended complaint in a securities fraud lawsuit brought by investors over the company's...To view the full article, register now.
Already a subscriber? Click here to view full article